India: In an attempt to ramp up the nation’s immunizations, the Centre booked 30 crore doses of the under-trial vaccine developed by Hyderabad based Biological-E pharmaceutical. An advance payment of ₹ 1,500 crores to the company has been sectioned for the second made-in-India vaccine as per the Union Health Ministry. In an official statement on … Continue reading Centre Orders 30 Crore Doses of COVID Vaccine from Biological-E